More articles about: Rheumatology
News Release
U-M Health ranked among nation’s best in more specialties than any other Michigan hospital by U.S. News & World Report
University of Michigan Health ranks among the nation’s best hospitals in more specialties than any other Michigan hospital, according to U.S. News and World Report’s Best Hospitals Rankings for 2024-2025.
Health Lab Podcast
Presenting: The Fundamentals
Today on Health Lab, we are sharing an episode of The Fundamentals, another podcast from the Michigan Medicine Podcast Network that just launched its second season earlier this month.
On this episode of The Fundamentals: "Cannabis and psychedelics: stigmatized substances or powerful therapeutics?" Dr. Kevin Boehnke talks about cannabis, psychedelics, and the increasing body of evidence for their legitimization as therapeutics.
Health Lab
Helpful enzymes vanish in many patients with antiphospholipid syndrome
Researchers recently revealed a new mechanism behind antiphospholipid syndrome that the investigators hope will eventually allow treatments to be targeted closer to the source of the problem.
Health Lab
Long COVID-19 is linked to chronic pain conditions
Therapies for pain conditions like fibromyalgia provide clues for helping those with long COVID-19
Health Lab
Unveiling potential diagnostic, treatment target for APS-related thrombocytopenia
Researchers at the University of Michigan Health have unveiled a new mechanism that drives thrombocytopenia and a potential clinically actionable biomarker for antiphospholipid syndrome associated thrombocytopenia.
Health Lab
Novel antibody targets CD38 enzyme to treat systemic sclerosis
New study has identified an enzyme contributing to systemic sclerosis.
Health Lab
Research finds potential target for cardiovascular disease in diabetes
University of Michigan researchers found that the overproduction of neutrophil extracellular traps is an important contributing factor to vascular dysfunction in diabetes.
Health Lab
Novel anti-NET antibodies in a multinational cohort
A U-M led international team uncovers new autoantibodies in antiphospholipid syndrome patients, shedding light on disease development. Learn more about the research findings and how they may lead to new treatments.
Health Lab
Lupus: A frustrating diagnosis journey you don’t need to embark alone
Nicknamed the “invisible disease”, the autoimmune disorder comes with lifestyle changes that can be a challenging adjustment.
Health Lab
Tofacitinib shows promise in scleroderma patients, researchers are optimistic for next phase of study.
Phase I/II study of a rheumatoid arthritis drug used in systemic sclerosis shows signs of efficacy and RNA technology is instrumental in the discovery
Health Lab
Aching joints make older adults reach for many forms of pain relief – but health risks could follow
Arthritis – both osteoarthritis and rheumatoid arthritis – affects most adults over 50 and limits the activity of many. Pain drugs and supplements to ease pain can interact and cause health risks.
Health Lab
How the western diet and gut bacteria can lead to scarring, vessel damage in scleroderma
The same metabolite is linked to cardiovascular and metabolic diseases.
Health Lab
Pathway uncovered for greatest lupus genetic risk factor, study shows
The discovery could be a route to novel treatments for the autoimmune disease.
Health Lab
Drugs showing promise in cancer trials reduce scarring for scleroderma
The findings could lead to repurposing drugs for patients with the sometimes-fatal condition.
Health Lab
Study finds healthy-appearing lupus skin predisposed to flares, rashes
In patients with lupus, immune cells undergo an inflammatory transformation when migrating from the blood to the skin.
